Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema

Emphysema is an intractable pulmonary disease characterized by an inflammatory process of the airways and lung parenchyma and ongoing remodeling process in an attempt to restore lung structure. There is no effective drug therapy that regenerates lung tissue or prevents the progression of emphysema;...

Full description

Bibliographic Details
Main Authors: Gisele A Padilha, Isabela eHenriques, Miqueias eLopes-Pacheco, Soraia C Abreu, Milena V Oliveira, Marcelo M Morales, Lidia M Lima, Eliezer Jesus Barreiro, Pedro L Silva, Debora G Xisto, Patricia Rieken Macedo Rocco
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-09-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00267/full
id doaj-d9fb44f3cf7a471f86461800f35e0285
record_format Article
spelling doaj-d9fb44f3cf7a471f86461800f35e02852020-11-24T21:01:41ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2015-09-01610.3389/fphys.2015.00267157104Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysemaGisele A Padilha0Isabela eHenriques1Miqueias eLopes-Pacheco2Miqueias eLopes-Pacheco3Soraia C Abreu4Milena V Oliveira5Marcelo M Morales6Lidia M Lima7Eliezer Jesus Barreiro8Pedro L Silva9Debora G Xisto10Patricia Rieken Macedo Rocco11Federal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroFederal University of Rio de JaneiroEmphysema is an intractable pulmonary disease characterized by an inflammatory process of the airways and lung parenchyma and ongoing remodeling process in an attempt to restore lung structure. There is no effective drug therapy that regenerates lung tissue or prevents the progression of emphysema; current treatment is aimed at symptomatic relief. We hypothesized that LASSBio-596, a molecule with potent anti-inflammatory and immunomodulatory effects, might reduce pulmonary inflammation and remodeling and thus improve lung function in experimental emphysema. Emphysema was induced in BALB/c mice by intratracheal administration of porcine pancreatic elastase (0.1 IU) once weekly during 4 weeks. A control group received saline using the same protocol. After the last instillation of saline or elastase, dimethyl sulfoxide or LASSBio-596 were administered intraperitoneally, once daily for 8 days. After 24 h, in elastase-induced emphysema animals, LASSBio-596 yielded: 1) decreased mean linear intercept, hyperinflation and collagen fiber content, 2) increased elastic fiber content, 3) reduced number of M1 macrophages, 4) decreased tumor necrosis factor-α, interleukin-1β, interleukin-6, and transforming growth factor-beta protein levels in lung tissue, and increased vascular endothelial growth factor. These changes resulted in increased static lung elastance. In conclusion, LASSBio-596 therapy reduced lung inflammation, airspace enlargement, and small airway wall remodeling, thus improving lung function, in this animal model of elastase-induced emphysema.http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00267/fullEmphysemaInflammationmacrophageremodelingElastic fiber
collection DOAJ
language English
format Article
sources DOAJ
author Gisele A Padilha
Isabela eHenriques
Miqueias eLopes-Pacheco
Miqueias eLopes-Pacheco
Soraia C Abreu
Milena V Oliveira
Marcelo M Morales
Lidia M Lima
Eliezer Jesus Barreiro
Pedro L Silva
Debora G Xisto
Patricia Rieken Macedo Rocco
spellingShingle Gisele A Padilha
Isabela eHenriques
Miqueias eLopes-Pacheco
Miqueias eLopes-Pacheco
Soraia C Abreu
Milena V Oliveira
Marcelo M Morales
Lidia M Lima
Eliezer Jesus Barreiro
Pedro L Silva
Debora G Xisto
Patricia Rieken Macedo Rocco
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
Frontiers in Physiology
Emphysema
Inflammation
macrophage
remodeling
Elastic fiber
author_facet Gisele A Padilha
Isabela eHenriques
Miqueias eLopes-Pacheco
Miqueias eLopes-Pacheco
Soraia C Abreu
Milena V Oliveira
Marcelo M Morales
Lidia M Lima
Eliezer Jesus Barreiro
Pedro L Silva
Debora G Xisto
Patricia Rieken Macedo Rocco
author_sort Gisele A Padilha
title Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
title_short Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
title_full Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
title_fullStr Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
title_full_unstemmed Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
title_sort therapeutic effects of lassbio-596 in an elastase-induced mouse model of emphysema
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2015-09-01
description Emphysema is an intractable pulmonary disease characterized by an inflammatory process of the airways and lung parenchyma and ongoing remodeling process in an attempt to restore lung structure. There is no effective drug therapy that regenerates lung tissue or prevents the progression of emphysema; current treatment is aimed at symptomatic relief. We hypothesized that LASSBio-596, a molecule with potent anti-inflammatory and immunomodulatory effects, might reduce pulmonary inflammation and remodeling and thus improve lung function in experimental emphysema. Emphysema was induced in BALB/c mice by intratracheal administration of porcine pancreatic elastase (0.1 IU) once weekly during 4 weeks. A control group received saline using the same protocol. After the last instillation of saline or elastase, dimethyl sulfoxide or LASSBio-596 were administered intraperitoneally, once daily for 8 days. After 24 h, in elastase-induced emphysema animals, LASSBio-596 yielded: 1) decreased mean linear intercept, hyperinflation and collagen fiber content, 2) increased elastic fiber content, 3) reduced number of M1 macrophages, 4) decreased tumor necrosis factor-α, interleukin-1β, interleukin-6, and transforming growth factor-beta protein levels in lung tissue, and increased vascular endothelial growth factor. These changes resulted in increased static lung elastance. In conclusion, LASSBio-596 therapy reduced lung inflammation, airspace enlargement, and small airway wall remodeling, thus improving lung function, in this animal model of elastase-induced emphysema.
topic Emphysema
Inflammation
macrophage
remodeling
Elastic fiber
url http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00267/full
work_keys_str_mv AT giseleapadilha therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT isabelaehenriques therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT miqueiaselopespacheco therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT miqueiaselopespacheco therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT soraiacabreu therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT milenavoliveira therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT marcelommorales therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT lidiamlima therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT eliezerjesusbarreiro therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT pedrolsilva therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT deboragxisto therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
AT patriciariekenmacedorocco therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
_version_ 1716777284038295552